Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 571 of 1,261

  1. US 9951141

    Antibody-drug conjugates, their preparation and their therapeutic use

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  2. US 9944740

    Sugar containing, amphiphilic copolymers

    Regents of the University of Minnesota · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  3. US 9944951

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  4. US 9944927

    Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  5. US 9944929

    UNA single stranded oligomers for therapeutics

    ARCTURUS THERAPEUTICS, INC. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  6. US 9944918

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  7. US 9944626

    6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  8. US 9944652

    Deuterated amlexanox

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  9. US 9944671

    Compositions and methods directed to treating liver fibrosis

    Alnylam Pharmaceuticals, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  10. US 9944637

    P2X3 and/or P2X2/3 compounds and methods

    Asana BioSciences, LLC · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  11. US 9944596

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  12. US 9944583

    Methods for ameliorating and preventing central nervous system inflammation

    The Regents of the University of California · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  13. US 9943605

    Polymer-semaxanib moiety conjugates

    Nektar Therapeutics · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  14. US 9943601

    Etanercept formulations stabilized with combinations of sugars and polyols

    Coherus BioSciences, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  15. US 9943565

    Methods and compositions for treating trinucleotide repeat disorders

    Sangamo Therapeutics, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  16. US 9943545

    Stem cell culture media and methods of enhancing cell survival

    Fate Therapeutics, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  17. US 9943594

    Methods for the treatment of rheumatoid arthritis

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  18. US 9943524

    Use of alkaloid in preparing pharmaceutical compositions for preventing or treating pulmonary fibrosis

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  19. US 9943526

    Optimizing mifepristone levels for cushing's patients

    Corcept Therapeutics Incorporated · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  20. US 9943538

    2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

    Ionis Pharmaceuticals, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  21. US 9943490

    Composite flash-precipitated nanoparticles

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  22. US 9943496

    Dietary supplement based on ethyl ferulate

    LABORATORIOS MINKAB, S.A. DE C.V. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  23. US 9944926

    Induced exon inclusion in spinal muscle atrophy

    Sarepta Therapeutics, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  24. US 9943539

    2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations

    Ionis Pharmaceuticals, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.